Recordati acquires 67% stake in Opalia Pharma - MarketLine Financial Deals

Recordati acquires 67% stake in Opalia Pharma

Recordati acquires 67% stake in Opalia Pharma - MarketLine Financial Deals
Recordati acquires 67% stake in Opalia Pharma
Published Jul 24, 2013
3 pages — Published Jul 24, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Recordati S.p.A., an Italy-based company engaged in the research, development, production and marketing of pharmaceuticals and pharmaceutical chemicals, has acquired approximately 67% of the share capital of Opalia Pharma.

  
Source:
Document ID
MA141073_130815
Country
Country
Ticker
RECI=IT
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Recordati acquires 67% stake in Opalia Pharma" Jul 24, 2013. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Recordati-acquires-67-stake-in-Opalia-Pharma-2052-96535>
  
APA:
MarketLine Financial Deals. (2013). Recordati acquires 67% stake in Opalia Pharma Jul 24, 2013. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Recordati-acquires-67-stake-in-Opalia-Pharma-2052-96535>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.